Clinical data builds with CR in testicular cancer, enrollment in Phase 2 gastric trial, and new data in PD-1–resistant tumors ...

A project from Metro Boomin and Curren$y is in the works. The rapper/producer duo took to social media to tease the arrival ...

Drake starred in an ad for his “Summer Mink” fragrance, with the short clip posted to his Instagram. The video sees the ...

Q1 2025 Earnings Call Transcript May 15, 2025 Operator: Thank you for standing by. My name is Rochelle, and I will be your ...

Analysts are estimating that MiNK Therapeutics will report an earnings per share (EPS) of $-0.71. MiNK Therapeutics bulls ...

MiNK Therapeutics Inc (INKT) showcases promising clinical progress and strategic partnerships while navigating financial constraints and funding delays.

A 2-year-old boy survived a fall from the 15th floor of a high-rise apartment building in Silver Spring, Maryland, when he ...

MiNK Therapeutics, Inc. announced its first-quarter 2025 financial results and highlighted significant progress in its development of allogeneic invariant natural killer T (iNKT) cell therapies.

New mapping of Sites of Scientific Interest across England and Wales has revealed thousands of sightings of non-native ...

Skyline Lodge in Highlands, NC serves up all of this and more as a backdrop for spring trends. It’s easy to escape in style ...

Gov. Andy Beshear says the death toll is expected to rise as more information comes in following storms that struck Kentucky.

NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf invariant natural ...